← Back to Search

Exercise Intervention for Young Cancer Survivors

N/A
Recruiting
Led By Smita Dandekar, MD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

Study Summary

This trial will test whether adding an exercise intervention to standard cancer care can improve pain, decrease the need for pain meds, and improve patients' quality of life.

Who is the study for?
This trial is for Adolescent and Young Adult (AYA) cancer survivors, aged 17-39, who are less than a year post-cancer therapy. They must speak English, be stable post-treatment, able to consent and attend three visits at Penn State Health Milton S. Hershey Medical Center. Participants with chronic pain and access to wifi-enabled devices can join; those over a year post-therapy or with contraindications to exercise cannot.Check my eligibility
What is being tested?
The study tests if adding an exercise program to standard care after cancer treatment helps reduce pain without the need for medication in AYA survivors compared to standard care alone. It aims to see if this approach is practical and improves functional and psychosocial outcomes.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include typical risks associated with physical activity such as muscle soreness or strain especially given that participants are recent cancer survivors.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, week 4, week 8, week 12 and week 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4, week 8, week 12 and week 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of the intervention
Interventional procedure
Secondary outcome measures
Pain
Pharmaceutical Preparations
Measure changes in patient functional outcomes ("Timed Up and Go" test)
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard post-cancer directed treatment care control groupExperimental Treatment1 Intervention
Group II: Physical activity intervention coupled with standard post-cancer directed treatment care groupExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
494 Previous Clinical Trials
2,798,822 Total Patients Enrolled
Smita Dandekar, MDPrincipal InvestigatorPenn State College of Medicine
2 Previous Clinical Trials
60 Total Patients Enrolled

Media Library

Physical activity intervention Clinical Trial Eligibility Overview. Trial Name: NCT05562570 — N/A
Adolescent and Young Adult Cancer Survivors Research Study Groups: Standard post-cancer directed treatment care control group, Physical activity intervention coupled with standard post-cancer directed treatment care group
Adolescent and Young Adult Cancer Survivors Clinical Trial 2023: Physical activity intervention Highlights & Side Effects. Trial Name: NCT05562570 — N/A
Physical activity intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05562570 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the ultimate aims of this medical research?

"This intervention is undergoing a Baseline evaluation in order to assess its viability. The secondary outcomes are physical function tests including the 6-min walking test, grip strength test and "Timed Up and Go" Test; longer durations for the former two indicate greater physical function while shorter durations suggest higher levels of functionality for the latter."

Answered by AI

Are recruitment efforts still underway for this research endeavor?

"According to the data available on clinicaltrials.gov, this particular medical trial is no longer actively recruiting participants as it was last updated in October of 2022. Nevertheless, there are presently 1 other trials that are accepting enrolments."

Answered by AI
~4 spots leftby Sep 2024